Spotlight on sertraline in the management of major depressive disorder in elderly patients

CNS Drugs

Volumn 16, Issue 11, 2002, Pages 789-794

  Muijsers, Richard B R ^a   Plosker, Greg L ^a   Noble, Stuart ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ANTICHOLINERGIC EFFECT; ARTHRITIS; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COGNITION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EJACULATION DISORDER; ELDERLY CARE; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; HYPONATREMIA; INSOMNIA; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA; PHARMACODYNAMICS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; SWEATING; TASTE DISORDER; TRANQUILIZING ACTIVITY; VASCULAR DISEASE; VERTIGO; XEROSTOMIA;

EID: 0036035817     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200216110-00011     Document Type: Review

References (39)

1. Murdoch D, McTavish D. Sertraline: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 1992 Oct; 44 (4): 604-24
2. Perry CM, Benfield P. Sertraline: An overview of its pharmacological properties and a review of its therapeutic efficacy in obsessive-compulsive disorder. CNS Drugs 1997; 7 (6): 480-500
3. DeVane CL. Differential pharmacology of newer antidepressants. J Clin Psychiatry 1998; 59 Suppl. 20: 85-93
4. Casacchia M, Pollice R, Matteucci M, et al. Brain serotonin and the mechanism of action of selective serotonin re-uptake inhibitors (SSRI). Arch Gerontol Geriatr 1998; 27 Suppl. 6:65-70
5. Nutt DJ, Forshall S, Bell C, et al. Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders. Eur Neuropsychopharmacol 1999 Jul; 9 (Suppl. 3): 81-6
6. Lane RM, O'Hanlon JF. Cognitive and psychomotor effects of antidepressants with emphasis on selective serotonin reuptake inhibitors and the depressed elderly patient. Ger J Psych 1999; 2 (1): 1-28
7. Schloss P, Williams DC. The serotonin transporter: A primary target for antidepressant drugs. J Psychopharmacol 1998; 12 (2): 115-21
8. MacQueen G, Born L, Steiner M. The selective serotonin reuptake inhibitor sertraline: Its profile and use in psychiatric disorders. CNS Drug Rev 2001 Spring; 7 (1): 1-24
9. Pfizer US. Zoloft (Sertraline) Full Prescibing Information [Online]. Available from URL: http://www.zoloft.com [Accessed Jan 2002]
10. Owens MJ, Knight DL, Nemeroff CB. Second-generation SSRIs: Human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 2001 Sep 1; 50 (5): 345-50
11. Bondareff W, Alpert M, Friedhoff AJ, et al. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry 2000 May; 157 (5): 729-36
12. Newhouse PA, Krishnan KRR, Doraiswamy PM, et al. A doubleblind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry 2000 Aug; 61 (8): 559-68
13. Hindmarch I, Shillingford J, Shillingford C. The effects of sertraline on psychomotor performance in elderly volunteers. J Clin Psychiatry 1990 Dec; 51 Suppl. B: 34-6
14. Mattila MJ, Saarialho-Kere U, Mattila M. Acute effects of sertraline, amitriptyline, and placebo on the psychomotor performance of healthy subjects over 50 years of age. J Clin Psychiatry 1988 Aug; 49 Suppl.: 52-8
15. Ronfeld RA, Tremaine LM, Wilner KD. Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Clin Pharmacokinet 1997; 32 (Suppl. 1): 22-30
16. Ronfeld RA, Wilner KD, Baris BA. Sertraline: Chronopharmacokinetics and the effect of coadministration with food. Clin Pharmacokinet 1997; 32 (Suppl. 1): 50-5
17. Catterson ML, Preskorn SH. Pharmacokinetics of selective serotonin reuptake inhibitors: Clinical relevance. Pharmacol Toxicol 1996 Apr; 78 (4): 203-8
18. van Harten J. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmacokinet 1993 Mar; 24 (3): 203-20
19. Xu Z-H, Wang W, Zhao X-J, et al. Evidence for involvement of polymorphic CYP2C19 and 2C9 in the N-demethylation of sertraline in human liver microsomes. Br J Clin Pharmacol 1999 Sep; 48 (3): 416-23
20. Demolis J-L, Angebaud P, Grange J-D, et al. Influence of liver cirrhosis on sertraline pharmacokinetics. Br J Clin Pharmacol 1996 Sep; 42 (3): 394-7
21. Preskorn SH. Outpatient Management of Depression: A Guide for the Practioner [Online]. Available from URL: http://www. preskorn.com/books [Accessed 2002 May 2]
22. Preskorn SH. Clinically relevant pharmacology of selective serotonin reuptake inhibitors, an overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clin Pharmacokinet 1997; 32 Suppl. 1: 1-21
23. Schneider LS, Clary CM, Finkel SI, et al. Sertraline in the treatment of elderly depression: Results of a large, multicenter, placebo-controlled trial [abstract/poster]. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13-18; Chicago, 134-5
24. Cohn CK, Shrivastava R, Mendels J, et al. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990 Dec; 51 Suppl. B: 28-33
25. Forlenza OV, Almeida OP, Stoppe Jr A, et al. Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: Results from a double-blind, randomized, controlled clinical trial. Int Psychogeriatr 2001 Mar; 13 (1): 75-84
26. Finkel SI, Richter EM, Clary CM, et al. Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression. Am J Geriatr Psychiatry 1999 Summer; 7 (3): 221-7
27. Finkel SI, Richter EM, Clary CM. Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older. Int Psychogeriatr 1999 Mar; 11 (1): 85-99
28. Sheikh J, Doraiswamy P, Clary C, et al. Late-life depression and medical comorbidity: Implications for treatment response. Int Psychogeriatr 2001; 13 Suppl. 2: 180S
29. Sheikh J, Doraiswamy P, Clary C, et al. Therapeutic response to sertraline in medically depressed elderly [poster P-124]. Tenth Congress of the International Psychogeriatric Association; 2001 Sep 9-14; Nice
30. Lyketsos CG, Sheppard J-ME, Steele CD, et al. Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: Initial results from the Depression in Alzheimer's Disease Study. Am J Psychiatry 2000 Oct; 157 (10): 1686-9
31. Taylor IC, McConnell JG. Severe hyponatraemia associated with selective serotonin reuptake inhibitors. Scott Med J 1995 Oct; 40 (5): 147-8
32. Kirby D, Ames D. Hyponatraemia and selective serotonin reuptake inhibitors in elderly patients. Int J Geriatr Psychiatry 2001; 16 (5): 484-93
33. Bradley ME, Foote EF, Lee EN, et al. Sertraline-associated syndrome of inappropriate antidiuretic hormone: Case report and review of the literature. Pharmacotherapy 1996; 16 (4): 680-3
34. Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry 1998; 59 Suppl. 15: 42-8
35. Veterans Health Administration. Practice Guideline for the Management of Major Depressive Disorder in Adults [Online]. Available from URL: http://www.oqp.med.va.gov/cpg [Accessed 2002 Sep 20]
36. Leonard BE. Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance. Drugs 1992; 43 Suppl. 2: 3-9, discussion 9-10
37. Solai LK, Mulsant BH, Pollock BG. Selective serotonin reuptake inhibitors for late-life depression: A comparative review. Drugs Aging 2001; 18 (5): 355-68
38. GlaxoSmithKline. Paxil (paroxetine) Full Prescribing Information (US) [Online]. Available from URL: http://www.gsk.com [Accessed Feb 2002]
39. Forest Pharmaceuticals. Celexa (Citalopram) Full Prescribing Information (US) [online]. Available from URL: http://www.celexa.com [Accessed Feb 2002]